Former Executive Vice President, CVS Health and President, CVS Caremark

As Executive Vice President, CVS Health and President, CVS Caremark – the company’s pharmacy benefits management (PBM) business – Derica Rice oversaw all aspects of the PBM business including sales and account management, operations, mail service pharmacy and specialty pharmacy. Rice was also responsible for driving PBM strategy, new business development and client relationship management and retention.
Rice joined CVS Health in 2018 from Eli Lilly and Company where he most recently served as Executive Vice President of global services and Chief Financial Officer.
Rice earned his master’s degree in business administration from Indiana University and a bachelor’s degree in electrical engineering from Kettering University.

Cost Management
GAO Reinforces Positive Impact of PBMs in Part D
New GAO report shows that rebates negotiated on behalf of payors may help control premiums and provides further proof of the value PBMs bring to payors and members. More
Commentary
Cost Management
Dynamic forces are affecting health and pharmacy care, affordability, and access. CVS Health is aligning efforts to address these challenges with... More
Video
Public Policy
Our perspective offered to Congress on solutions and policies that can help bring escalating drug prices under control. More
Commentary
Cost Management
As a health care innovation company, our steadfast focus is on helping to reduce costs and improve outcomes for our pharmacy benefit management (PBM) clients and their plan... More
Feature
Cost Management
A Guaranteed Net Cost model can adapt to evolving market trends and help payors stay ahead of manufacturer strategies such as authorized generics, and changing legislative... More
Briefing
Cost Management
The Guaranteed Net Cost model guarantees average net spend per prescription, after discounts and rebates, for each distribution channel. More
Feature
Cost Management
With prescription drug prices very much in the news, the question often asked is: Who is responsible for high drug prices? Pharmaceutical manufacturers — and no one else — set... More
Commentary